Tomer Berkovitz

Tomer Berkovitz is a Managing Partner at aMoon Fund, a venture capital firm based in the Center District of Israel. Before joining aMoon in 2018, he served as the Chief Financial Officer and Chief Operating Officer of the NASDAQ-listed biotechnology company Alcobra, where he oversaw its merger with Arcturus Therapeutics. Earlier in his career, Berkovitz worked as an investment banker at J.P. Morgan in New York, leading healthcare corporate finance advisory, and earned a PhD in Finance from Columbia Business School. At aMoon, which manages nearly $1 billion in total assets, he directs investments across the life sciences sector and has held board roles at publicly traded companies including Seer and SOPHiA GENETICS. His current professional focus centers on funding and scaling health technology startups that operate at the intersection of biotechnology and digital healthcare.